G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
about
Structural determinants involved in the formation and activation of G protein betagamma dimers.The C825T polymorphism of the G-protein β3 subunit gene and its association with hypertension and stroke: an updated meta-analysis.Genetics of antipsychotic treatment emergent weight gain in schizophrenia.Ablation of the GNB3 gene in mice does not affect body weight, metabolism or blood pressure, but causes bradycardia.Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.The genetics of normal platelet reactivity.β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variantImpaired 3',5'-cyclic adenosine monophosphate-mediated signaling in immediate early responsive gene X-1-deficient vascular smooth muscle cells.The Extended Nutrigenomics - Understanding the Interplay between the Genomes of Food, Gut Microbes, and Human HostThe role of G protein gene GNB3 C825T polymorphism in HIV-1 acquisition, progression and immune activation.The -308G/A of Tumor Necrosis Factor (TNF)-α and 825C/T of Guanidine Nucleotide Binding Protein 3 (GNB3) are associated with the onset of acute myocardial infarction and obesity in Taiwan.Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese populationMechanisms of disease: Mutations of G proteins and G-protein-coupled receptors in endocrine diseases.Migraine and ischaemic vascular events.Associations between migraine and cardiovascular disease.Future perspectives for the treatment of pulmonary arterial hypertension.The Gβ3 splice variant associated with the C825T gene polymorphism is an unstable and functionally inactive proteinGenetics of the cardiometabolic syndrome: new insights and therapeutic implications.SNPs in genes encoding G proteins in pharmacogenetics.Assessing gene-gene interactions in pharmacogenomics.Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients.Association between the G-protein β3 subunit C825T polymorphism with essential hypertension: a meta-analysis in Han Chinese population.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Hypertension, obesity and GNB 3 gene variants.GNB3 and FTO Polymorphisms and Pregnancy Weight Gain in Black Women.The prevalence of Gly972Arg and C825T polymorphisms in Slovak women with polycystic ovary syndrome and their relation to the metabolic syndrome.Gβ2 and Gβ4 participate in the opioid and adrenergic receptor-mediated Ca2+ channel modulation in rat sympathetic neurons.Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritis.Association of G-protein β3 subunit C825T polymorphism with essential hypertension: evidence from 63 729 subjects.Role of GNB3, NET, KCNJ11, TCF7L2 and GRL genes single nucleotide polymorphism in the risk prediction of type 2 diabetes mellitus.RNA Sequencing Reveals Novel Transcripts from Sympathetic Stellate Ganglia During Cardiac Sympathetic Hyperactivity.Improvement of Non-Steroidal Anti-Inflammatory Drug-Induced Gastrointestinal Symptoms during Proton Pump Inhibitor Treatment: Are G-Protein β3 Subunit Genotype, Helicobacter pylori Status, and Environmental Factors Response Modifiers?Hypothesis Driven Research and Molecular Mechanisms in Functional Dyspepsia: The Beginning of a Beautiful Friendship in Research and Practice?Gene–environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities Study
P2860
Q27865227-497725AA-8B75-40D8-B1D3-AC93C33C5498Q31120518-B54141FD-BAE2-4037-A627-46A6C4769D1DQ33257886-D20D3806-F2FE-4F11-B7C6-4A1435B5B2E5Q34160902-505CF771-5C97-4F75-AD16-E4DC021AEFA9Q34180253-8F4DF307-A3A3-4A84-B371-2031895715ABQ34282183-B98362EF-982E-4705-B879-4B31001CB6FFQ34779277-97DC1C7F-0ABD-48DC-B2B2-BF088605F8E5Q35168150-4D9805C9-AE11-4F41-B93F-7CAF2EFBC29FQ35711077-F08A69D6-8E04-4637-806A-C775808F3C22Q35753522-60E727E7-47A1-4F3E-B379-7CB792AF5085Q35795814-FC3B9947-F5BF-4640-BD4C-4397304687A7Q36501995-187848A3-2A5C-461A-9BE5-369E88F2DF33Q36672702-480B263B-40D0-4BB4-AE52-B5940E42FD38Q36895947-B2415211-5571-4FFB-8D0B-B0A66B931268Q36941889-97084A46-9BF2-48EC-B1FD-8AD9D8D4CF06Q36943648-490BDC75-6D97-412F-8CF4-6D844819FF5EQ37166934-0E859440-1699-4390-B95B-13EADC6F7032Q37362678-7BCB5321-ED42-4E1C-891B-B8E8D7B8713CQ37880876-906885CD-4E09-4928-8871-E0F432C03E1FQ37986775-AAB5351D-4C6E-4D9F-A3B3-5DFF32962F35Q38164430-04356478-C3A1-42CF-B841-34B381B233BBQ38415652-71BC6F3A-EE62-4867-8500-70ED74CDD960Q38842714-EBEE77C5-BD5A-4BB4-8D24-ED030E3B605DQ39746163-4425BAD5-E053-4F84-9E39-38AAC52CFBE4Q41127140-39FAB96F-D621-459B-ABE0-939432347711Q43156458-E121B3CC-6D3E-4919-8355-4E0E948607EAQ44334646-DC6EF365-7F70-4358-B407-D39019D23525Q44438694-A712450B-C60F-4579-9A64-7E8A25252CFAQ50982490-0E9FAB2F-F982-4DD6-8A0B-223C3F0A0598Q53937431-582DB1EB-D83F-490D-B1C6-17DC9D7F9B11Q55290820-2F34FEB2-85ED-430E-84DD-FEE69E4055C0Q57789427-37EDFDD2-3645-4CBE-9DAE-D08C98B2C8D5Q57789593-3884BE37-B637-45D1-94C4-FF4AC2484584Q59192489-3F328F5F-AD15-4F37-B7B0-4C9FD9AED4A3
P2860
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@ast
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@en
type
label
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@ast
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@en
prefLabel
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@ast
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@en
P1476
G protein polymorphisms in hypertension, atherosclerosis, and diabetes.
@en
P2093
Winfried Siffert
P356
10.1146/ANNUREV.MED.56.082103.104625
P577
2005-01-01T00:00:00Z